Bausch + LombvsMerck & Company

BLCO and MRK stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$143.93

Value $356B

-0.25%
MRK's page

Bausch + Lomb (BLCO) has a market value of $7.4B and Merck & Company (MRK) $356B. Over the last year, with dividends, BLCO moved +34.2% and MRK +59.5%. Dividend yield: BLCO none, MRK 2.36%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BLCO$7.4B

    MRK$356B

    MRK is 48 times BLCO

  • Revenue, 12 months

    BLCO$5.4B

    MRK$67.4B

    MRK is 12 times BLCO

  • Net income, 12 months

    BLCO-$111M

    MRK$2.5B

  • Operating margin

    BLCO7.1%

    MRK–

  • ROIC

    BLCO2.6%

    MRK3.9%

    1.3 points apart

  • P/E

    BLCO–

    MRK145.1

  • Dividend yield

    BLCO0.0%

    MRK2.4%

    2.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BLCO+33.8%

MRK+55.0%

100150202420252026
Returns by period
PeriodBLCOWith dividendsMRKWith dividends
1 year since November 14, 2025+34.2%Price +34.2%+59.5%Price +54.9%
3 years since November 17, 2023+33.8%+10.2% a yearPrice +33.8%+55.0%+15.7% a yearPrice +41.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BLCOBausch + LombMRKMerck & Company

Valuation

BLCOMRK
Valuation
Price$20.93$143.93
Market value$7.4B$356B
Enterprise value (EV)$11.9B$400B
P/E–145.1
P/E, 5-year median–14.8
P/B1.27.9
EV/EBIT31.184.0
Free cash flow yield3.4%4.1%

Results and growth

BLCOMRK
Results and growth
Revenue, 12 months$5.4B$67.4B
Net income, 12 months-$111M$2.5B
Free cash flow, 12 months$252M$14.7B
Earnings per share, 12 months-$0.32$0.98
Revenue growth, year on year6.5%1.3%
Revenue growth a year, past+8.4%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

BLCOMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin7.1%–
Net margin-2.1%3.6%
ROIC2.6%3.9%
ROE-1.7%5.2%

Balance sheet

BLCOMRK
Balance sheet
Cash$513M$9.7B
Total debt$5.0B$53.8B
Net debt / EBITDA5.65.7
Interest cover1.0×2.4×

Dividends and buybacks

BLCOMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.4%
Shareholder yield–3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BLCO or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Bausch + Lomb or Merck & Company?

By market value, Merck & Company ($356B) is about 48.0 times Bausch + Lomb ($7.4B), at today's prices.

How did BLCO and MRK stock do over the last 3 years?

Since November 17, 2023, BLCO's price moved +33.8% and MRK's +41.5%. With dividends: BLCO +33.8% (+10.2% a year), MRK +55.0% (+15.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, BLCO or MRK?

The dividend yield at today's price is none for Bausch + Lomb and 2.36% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, Bausch + Lomb or Merck & Company?

Over the last twelve months, the net margin was -2.1% for Bausch + Lomb and 3.6% for Merck & Company, and the operating margin 7.1% and –. Revenue was $5.4B and $67.4B.

Which is the better investment, Bausch + Lomb or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.